Coordinate Regulation of Transfusions by Uploading
NCT02851225 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2021-08-24
Summary
Currently in the Toulouse University Hospital, the organization of transfusion care for patients requiring regular transfusions is based on reading the biological results received by fax before confirming or disproving a planned hospitalization or program a new hospital if needed.
Remote transmission of laboratory results, replacing fax communication might facilitate the coordination of care that results from these laboratory results and provide a better respect of the Plan Custom Care Transfusion (PPST).
The investigators offer organization of transfusion supportive care for patients with conditions requiring biological monitoring using the techniques of information and communication telemedicine.
Primary objective
\- Assess the feasibility of setting up an upload procedure biological results in the treatment of transfusion supportive care.
Secondary objectives
* Assess the evolution of the quality of life of patients during the treatment
* Assess changes in patient satisfaction over the support
* Assess the evolution of the satisfaction of the medical team at home and at Toulouse University Hospital
* Describe the programming time (hospitalization, consultations)
* Estimate the loss of biological results
* Assessment of the descriptive use of hospitalization, consultation and biological examinations in both groups. This remedy shall be valued in Euros thanks to GHS rates for hospitalizations, general nomenclature for Professional acts (NGAP) and biology nomenclature (NABM) for biological tests.
Conditions
- Neoplasm, Uncertain Whether Benign or Malignant
Interventions
- OTHER
-
telemedicine transmission of biological results
telemedicine transmission of biological informations
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Principal Investigators
-
Odile Beyne Rauzy, MD · University Hospital, Toulouse
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-02
- Primary Completion
- 2021-05-11
- Completion
- 2021-05-11
Countries
- France
Study Locations
More Related Trials
-
Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies
NCT02885038 ·Status: COMPLETED
-
Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03357172 ·Status: RECRUITING ·Phase: NA
-
The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients
NCT02069210 ·Status: UNKNOWN
-
Pulmonary Complications of Allografts
NCT01219972 ·Status: COMPLETED
-
Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation
NCT00461955 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of the Feasibility of Setting up a Logbook for Allogeneic Haematopoietic Stem Cell Patients at the University Hospital of Amiens
NCT03149952 ·Status: WITHDRAWN ·Phase: NA
-
Cord Blood Transplantation in Severe Aplastic Anemia
NCT01343953 ·Status: COMPLETED ·Phase: PHASE2
-
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
NCT02549222 ·Status: COMPLETED
-
Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
NCT02035189 ·Status: COMPLETED
-
Screening for Subjects to Participate in Studies of Blood Disorders
NCT00695123 ·Status: COMPLETED
-
Transplantation of Ex-vivo Expanded Cord Blood Stems Cells
NCT01034449 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Efficacy of Platelet Transfusion
NCT06805097 ·Status: RECRUITING
-
Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant
NCT04323605 ·Status: UNKNOWN ·Phase: NA
-
Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients
NCT05662631 ·Status: COMPLETED ·Phase: NA
-
Cryopreservation of White Blood Cells Before Their UVA Irradiation for Graft Versus Host Disease Treatment
NCT03361254 ·Status: UNKNOWN ·Phase: NA
-
RElapse After Allograft: Link Between LoCus of Control and QualiTy of Life
NCT05258929 ·Status: TERMINATED
-
Study of Drug Acceptance and Its Persistence Over Time in Patients Receiving a Haematopoietic Stem Cell Allograft
NCT05164835 ·Status: UNKNOWN ·Phase: NA
-
Second Haplo-transplantation for Graft Failure
NCT06512519 ·Status: RECRUITING ·Phase: NA
-
Toward Immune Biomarkers for Tolerance and GvHD in Humans
NCT02319226 ·Status: UNKNOWN
-
Biobank Based on the i-Share Student Cohort
NCT02568371 ·Status: COMPLETED
-
Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France
NCT04282421 ·Status: COMPLETED
-
Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03965429 ·Status: ACTIVE_NOT_RECRUITING
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft
NCT03280290 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.
NCT05752123 ·Status: TERMINATED ·Phase: NA